FindTrial
Sign In

Concurrent chemoradiotherapy with S-1 and cisplatin

4 trials

Sponsors

Yamamoto Sachiko, Japan Clinical Oncology Group(JCOG), Japan Clinical Oncology Group (JCOG), Osaka International Cancer Institute

Conditions

Esophageal cancer Esophageal cancerclinical stage IA esophageal canceresophageal neoplasmunresectable locally advanced squamous cell carcinoma of the head and neck

Phase 1

Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
Active, not recruitingJPRN-UMIN000000710
Japan Clinical Oncology Group(JCOG)esophageal neoplasm
Start: 2007-05-01Target: 81Updated: 2026-06-29

Phase 2

Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
Active, not recruitingJPRN-UMIN000001272
Japan Clinical Oncology Group (JCOG)unresectable locally advanced squamous cell carcinoma of the head and neck
Start: 2008-07-01Target: 45Updated: 2026-06-29
Phase II study of chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal cancer (definitive chemoradiotherapy)
Active, not recruitingJPRN-UMIN000014683
Osaka International Cancer Instituteclinical stage IA esophageal cancer
Start: 2014-07-30Target: 38Updated: 2026-06-29
Phase II study of definitive chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal squamous cell carcinoma. (SP-RT)
Active, not recruitingJPRN-jRCTs051180078
Yamamoto SachikoEsophageal cancer Esophageal cancer
Start: 2014-06-01Target: 76Updated: 2026-06-29

Related Papers

Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)
Japanese Journal of Clinical Oncology2019-07-172 citations
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1)
Annals of Oncology2018-10-01
Phase I/<scp>II</scp> trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage <scp>II</scp>/<scp>III</scp> esophageal carcinoma (<scp>JCOG</scp> 0604)
Cancer Science2015-08-0630 citations